Literature DB >> 24211261

Prostate MRI: can we do without DCE sequences in 2013?

P Puech1, A Sufana-Iancu, B Renard, L Lemaitre.   

Abstract

Multiparametric MRI (mp-MRI) of the prostate currently provides stable and reproducible performances. The usefulness of dynamic contrast-enhanced (DCE) sequences is currently challenged, as they sometimes only confirm what has already been observed on diffusion-weighted imaging (DWI) and require the additional purchase of a contrast agent. Eliminating these sequences may help accelerate the use of MRI in addition to, or in lieu of, prostate biopsies in selected patients. However, many studies show that these sequences can detect lesions invisible on T2-weighted and diffusion-weighted images, better assess cancer extension and aggressiveness, and finally help detecting recurrence after treatment. We present the various applications of dynamic MRI and discuss the possible consequences of its omission from the current protocol.
Copyright © 2013 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer; Diffusion-weighted-imaging (DWI); Perfusion (DCE-MRI); Prostate

Mesh:

Substances:

Year:  2013        PMID: 24211261     DOI: 10.1016/j.diii.2013.09.010

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  11 in total

1.  Prostate cancer: MRI-TRUS fusion biopsy versus 12-core systematic biopsy.

Authors:  Gauthami Churukanti; Mohummad M Siddiqui
Journal:  Nat Rev Urol       Date:  2015-06-16       Impact factor: 14.432

2.  Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?

Authors:  Daniel Junker; Fabian Steinkohl; Veronika Fritz; Jasmin Bektic; Theodoros Tokas; Friedrich Aigner; Thomas R W Herrmann; Michael Rieger; Udo Nagele
Journal:  World J Urol       Date:  2018-08-04       Impact factor: 4.226

3.  Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.

Authors:  Yuji Iyama; Takeshi Nakaura; Kazuhiro Katahira; Ayumi Iyama; Yasunori Nagayama; Seitaro Oda; Daisuke Utsunomiya; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

Review 4.  Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer.

Authors:  Baris Turkbey; Anna M Brown; Sandeep Sankineni; Bradford J Wood; Peter A Pinto; Peter L Choyke
Journal:  CA Cancer J Clin       Date:  2015-11-23       Impact factor: 508.702

5.  MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy.

Authors:  Lars Schimmöller; Michael Quentin; Christian Arsov; Andreas Hiester; Christian Buchbender; Robert Rabenalt; Peter Albers; Gerald Antoch; Dirk Blondin
Journal:  Eur Radiol       Date:  2014-06-28       Impact factor: 5.315

6.  Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results.

Authors:  Thomas Auer; Michael Edlinger; Jasmin Bektic; Udo Nagele; Thomas Herrmann; Georg Schäfer; Friedrich Aigner; Daniel Junker
Journal:  World J Urol       Date:  2016-08-10       Impact factor: 4.226

7.  Biparametric versus multiparametric MRI in the diagnosis of prostate cancer.

Authors:  Karen Cecilie Duus Thestrup; Vibeke Logager; Ingerd Baslev; Jakob M Møller; Rasmus Hvass Hansen; Henrik S Thomsen
Journal:  Acta Radiol Open       Date:  2016-08-17

Review 8.  Dynamic contrast-enhanced magnetic resonance imaging of prostate cancer: A review of current methods and applications.

Authors:  Yousef Mazaheri; Oguz Akin; Hedvig Hricak
Journal:  World J Radiol       Date:  2017-12-28

9.  Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers.

Authors:  Olivier Rouvière; Tristan Dagonneau; Fanny Cros; Flavie Bratan; Laurent Roche; Florence Mège-Lechevallier; Alain Ruffion; Sébastien Crouzet; Marc Colombel; Muriel Rabilloud
Journal:  PLoS One       Date:  2017-06-09       Impact factor: 3.240

10.  Accuracy of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate cancer: systematic review and meta-analysis.

Authors:  Zhiqiang Chen; Yi Zheng; Guanghai Ji; Xinxin Liu; Peng Li; Lei Cai; Yulin Guo; Jian Yang
Journal:  Oncotarget       Date:  2017-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.